Camarda Financial Advisors’s CONMED CNMD Stock Holding History

Camarda Financial Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5	Closed	–	–	122
2019 Q2	$0	Hold	5	–	–	﹤0.01%	502
2019 Q1	$0	Buy	+5	New	+$363	﹤0.01%	538

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Camarda Financial Advisors's CNMD Position: Q3 2019 in Review

Camarda Financial Advisors sold out of CONMED (CNMD) in Q3 2019, closing a stake of 5 shares.

Camarda Financial Advisors first reported a position in CNMD in Q1 2019 and held it in 2 quarters. The position peaked at $0 in Q2 2019. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

Camarda Financial Advisors reported no remaining CONMED position as of Q3 2019 after selling out during the quarter.
Camarda Financial Advisors sold 5 CONMED shares in Q3 2019.
Camarda Financial Advisors first reported a position in CONMED in Q1 2019 and held it in 2 quarters.
Camarda Financial Advisors's CONMED position peaked at $0 in Q2 2019.
234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.